Aamir Aziz

1.0k total citations · 1 hit paper
34 papers, 664 citations indexed

About

Aamir Aziz is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Aamir Aziz has authored 34 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Ophthalmology, 13 papers in Molecular Biology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Aamir Aziz's work include Retinal Diseases and Treatments (14 papers), Retinal and Optic Conditions (9 papers) and Retinal Imaging and Analysis (9 papers). Aamir Aziz is often cited by papers focused on Retinal Diseases and Treatments (14 papers), Retinal and Optic Conditions (9 papers) and Retinal Imaging and Analysis (9 papers). Aamir Aziz collaborates with scholars based in United States, Pakistan and Saudi Arabia. Aamir Aziz's co-authors include Arshad M. Khanani, Carl J. Danzig, Christina Y. Weng, Jay Chhablani, Mahima Jhingan, Sumit Randhir Singh, Peter K. Kaiser, Mathew Thomas, Szilárd Kiss and Fazal Rahim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Investigative Ophthalmology & Visual Science and Glia.

In The Last Decade

Aamir Aziz

33 papers receiving 651 citations

Hit Papers

The real-world efficacy and safety of faricimab in neovas... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aamir Aziz United States 15 385 274 218 68 47 34 664
Anastasia Slobodnick United States 5 130 0.3× 111 0.4× 250 1.1× 37 0.5× 55 1.2× 10 577
Tian Zheng China 10 51 0.1× 47 0.2× 172 0.8× 19 0.3× 53 1.1× 36 387
Amira Othman United States 9 104 0.3× 40 0.1× 177 0.8× 7 0.1× 21 0.4× 15 527
Wenyuan Li China 12 58 0.2× 36 0.1× 216 1.0× 4 0.1× 21 0.4× 44 493
Chunyan Fu China 11 38 0.1× 31 0.1× 139 0.6× 6 0.1× 10 0.2× 21 394
Dan-dan Zhou China 12 57 0.1× 76 0.3× 248 1.1× 8 0.1× 2 0.0× 24 445
Sung Jin Kim South Korea 9 13 0.0× 48 0.2× 61 0.3× 21 0.3× 39 0.8× 52 370
Steven Kane United States 11 138 0.4× 184 0.7× 90 0.4× 3 0.0× 4 0.1× 22 423
Xiaoqin Zheng China 13 23 0.1× 12 0.0× 156 0.7× 21 0.3× 35 0.7× 27 397
Taeko Hotta Japan 12 13 0.0× 22 0.1× 153 0.7× 42 0.6× 20 0.4× 46 469

Countries citing papers authored by Aamir Aziz

Since Specialization
Citations

This map shows the geographic impact of Aamir Aziz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aamir Aziz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aamir Aziz more than expected).

Fields of papers citing papers by Aamir Aziz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aamir Aziz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aamir Aziz. The network helps show where Aamir Aziz may publish in the future.

Co-authorship network of co-authors of Aamir Aziz

This figure shows the co-authorship network connecting the top 25 collaborators of Aamir Aziz. A scholar is included among the top collaborators of Aamir Aziz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aamir Aziz. Aamir Aziz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aziz, Aamir, et al.. (2024). Approved treatments for neovascular age-related macular degeneration: current safety and future directions. Expert Opinion on Drug Safety. 23(9). 1109–1114. 1 indexed citations
2.
Aziz, Aamir, et al.. (2023). Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration. Clinical ophthalmology. Volume 17. 321–327. 32 indexed citations
3.
Aziz, Aamir, et al.. (2023). Cooling Anesthesia for Intravitreal Injections – A Review. Clinical ophthalmology. Volume 17. 197–207. 2 indexed citations
4.
Ullah, Amin, Tehreem Ayaz, Aamir Aziz, et al.. (2023). Phycoremediation of industrial wastewater using Vaucheria debaryana and Cladophora glomerata. Environmental Monitoring and Assessment. 195(7). 9 indexed citations
5.
Ahmad, Sajjad, Taghreed N. Almanaa, Saifullah Khan, et al.. (2023). Identification of potential drug molecules against fibroblast growth factor receptor 3 (FGFR3) by multi-stage computational-biophysics correlate. Journal of Biomolecular Structure and Dynamics. 43(3). 1240–1248. 20 indexed citations
6.
Khanani, Arshad M., Mathew Thomas, Aamir Aziz, et al.. (2022). Review of gene therapies for age-related macular degeneration. Eye. 36(2). 303–311. 80 indexed citations
7.
Iqbal, Zafar, et al.. (2022). Time for culture conversion and its associated factors in multidrug-resistant tuberculosis patients at a tertiary level hospital in Peshawar, Pakistan. Pakistan Journal of Medical Sciences. 38(4). 1009–1015. 6 indexed citations
8.
Khanani, Arshad M., Raj K. Maturi, Nika Bagheri, et al.. (2022). A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy. SHILAP Revista de lepidopterología. 2(2). 100154–100154. 15 indexed citations
9.
Wang, Rui, Raziyeh Mahmoudzadeh, Mirataollah Salabati, et al.. (2022). Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII). BMJ Open Ophthalmology. 7(1). e001188–e001188. 18 indexed citations
10.
Aziz, Aamir, et al.. (2022). Forward Head Posture in Young Adults: A Systematic Review. 32–35. 3 indexed citations
11.
Khanani, Arshad M., Aamir Aziz, Christina Y. Weng, et al.. (2021). Port delivery system: a novel drug delivery platform to treat retinal diseases. Expert Opinion on Drug Delivery. 18(11). 1571–1576. 19 indexed citations
12.
Aziz, Aamir, Arshad M. Khanani, Nikolas London, et al.. (2021). Real World Efficacy and Safety of Brolucizumab in Neovascular AMD: The REBEL Study. Investigative Ophthalmology & Visual Science. 62(8). 451–451. 8 indexed citations
13.
Aziz, Aamir, et al.. (2021). Faricimab: An Emerging Therapy for the Treatment of Neovascular Age-related Macular Degeneration. European Ophthalmic Review. 15(1). 23–23. 1 indexed citations
14.
Sadiq, Asma, Alam Khan, Aamir Aziz, et al.. (2021). Rotavirus gastroenteritis in Pakistan, 2018: updated disease burden. BMC Infectious Diseases. 21(1). 426–426. 6 indexed citations
15.
Khanani, Arshad M., Matthew W. Russell, Aamir Aziz, et al.. (2021). Angiopoietins as Potential Targets in Management of Retinal Disease. Clinical ophthalmology. Volume 15. 3747–3755. 33 indexed citations
16.
Ullah, Hayat, Hafeez Ullah, Muhammad Taha, et al.. (2021). Synthesis, In Vitro α-Amylase Activity, and Molecular DockingStudy of New Benzimidazole Derivatives. Russian Journal of Organic Chemistry. 57(6). 968–975. 31 indexed citations
17.
Aziz, Aamir, et al.. (2020). Treatment Outcomes of Short Course Regimens for Multidrug-Resistant Tuberculosis patients in Peshawar. 26(4). 210–216. 1 indexed citations
18.
Khanani, Arshad M., et al.. (2020). Purtscher's-like retinopathy associated with acute pancreatitis. American Journal of Ophthalmology Case Reports. 20. 100892–100892. 7 indexed citations
19.
Aziz, Aamir, et al.. (2020). Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020. Asia-Pacific Journal of Ophthalmology. 9(3). 250–259. 58 indexed citations
20.
Healy, Donagh, Aamir Aziz, Chee Siong Wong, et al.. (2013). A descriptive cost analysis study of cases of right iliac fossa pain. International Journal of Surgery. 11(7). 524–528. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026